41 related articles for article (PubMed ID: 32036088)
1. Pleural effusion supernatant: a reliable resource for cell-free DNA in molecular testing of lung cancer.
Thakur S; Rathor A; Jain S; Nambirajan A; Khurana S; Malik PS; Jain D
J Am Soc Cytopathol; 2024; 13(4):291-302. PubMed ID: 38704351
[TBL] [Abstract][Full Text] [Related]
2. Detection of EGFR mutation in supernatant, cell pellets of pleural effusion and tumor tissues from non-small cell lung cancer patients by high resolution melting analysis and sequencing.
Lin J; Gu Y; Du R; Deng M; Lu Y; Ding Y
Int J Clin Exp Pathol; 2014; 7(12):8813-22. PubMed ID: 25674250
[TBL] [Abstract][Full Text] [Related]
3. Performance of SHOX2 and RASSF1A methylation assay in supernatants and matched cell pellets for the diagnosis of malignant pleural effusion.
Zhang N; Li Y; Zhang H; Dong Y; Zhang C; Du W; Long C; Xing X; Li K; Liu Z; Chen X; Zhang L; Xu F; Fu Y; Tan J; She B; Che N
Clin Chim Acta; 2024 Jan; 553():117699. PubMed ID: 38072300
[TBL] [Abstract][Full Text] [Related]
4. Implementation of an ISO 15189 accredited next generation sequencing service for cell-free total nucleic acid (cfTNA) analysis to facilitate driver mutation reporting in blood: the experience of a clinical diagnostic laboratory.
Werner R; Crosbie R; Dorney M; Connolly A; Collins D; Hand CK; Burke L
J Clin Pathol; 2024 Jun; ():. PubMed ID: 38914446
[TBL] [Abstract][Full Text] [Related]
5. Clinical application of the Lung Cancer Compact Panel
Kunimasa K; Tamiya M; Inoue T; Kawamura T; Miyazaki A; Kojitani Y; Honma K; Nishino K
Lung Cancer; 2024 Mar; 189():107498. PubMed ID: 38324922
[TBL] [Abstract][Full Text] [Related]
6. A low-coverage liquid biopsy for lung cancer.
Willson J
Nat Cancer; 2023 Dec; 4(12):1647. PubMed ID: 38102361
[No Abstract] [Full Text] [Related]
7. Exosome-based detection of EGFR T790M in plasma and pleural fluid of prospectively enrolled non-small cell lung cancer patients after first-line tyrosine kinase inhibitor therapy.
Kim Y; Shin S; Lee KA
Cancer Cell Int; 2021 Jan; 21(1):50. PubMed ID: 33435996
[TBL] [Abstract][Full Text] [Related]
8. Prospective evaluation of NGS-based liquid biopsy in untreated late stage non-squamous lung carcinoma in a single institution.
Heeke S; Hofman V; Ilié M; Allegra M; Lespinet V; Bordone O; Benzaquen J; Boutros J; Poudenx M; Lalvée S; Tanga V; Salacroup C; Bonnetaud C; Marquette CH; Hofman P
J Transl Med; 2020 Feb; 18(1):87. PubMed ID: 32066459
[TBL] [Abstract][Full Text] [Related]
9. Development of an optimal protocol for molecular profiling of tumor cells in pleural effusions at single-cell level.
Nakamura IT; Ikegami M; Hasegawa N; Hayashi T; Ueno T; Kawazu M; Yagishita S; Goto Y; Shinno Y; Kojima Y; Takamochi K; Takahashi F; Takahashi K; Mano H; Kohsaka S
Cancer Sci; 2021 May; 112(5):2006-2019. PubMed ID: 33484069
[TBL] [Abstract][Full Text] [Related]
10. Analysis of CD4, CD8, CD19, CD56-16, CD64, QuantiFERON biomarkers in exudative lymphocyte-dominant pleural effusion.
Mehraban Z; Pourdowlat G; Mortaz E; Atefeh A; Ghaforian AR; MalAmir MD; Bakhtiari N
J Family Med Prim Care; 2022 Nov; 11(11):6843-6847. PubMed ID: 36993098
[TBL] [Abstract][Full Text] [Related]
11. The Liquid Biopsy for Lung Cancer: State of the Art, Limitations and Future Developments.
Di Capua D; Bracken-Clarke D; Ronan K; Baird AM; Finn S
Cancers (Basel); 2021 Aug; 13(16):. PubMed ID: 34439082
[TBL] [Abstract][Full Text] [Related]
12. Next-Generation Sequencing of Cell-Free DNA Extracted From Pleural Effusion Supernatant: Applications and Challenges.
Patel A; Hissong E; Rosado L; Burkhardt R; Cong L; Alperstein SA; Siddiqui MT; Park HJ; Song W; Velu PD; Rennert H; Heymann JJ
Front Med (Lausanne); 2021; 8():662312. PubMed ID: 34195208
[TBL] [Abstract][Full Text] [Related]
13. Sputum cell-free DNA: Valued surrogate sample for the detection of EGFR exon 20 p.T790M mutation in patients with advanced lung adenocarcinoma and acquired resistance to EGFR-TKIs.
Wang Z; Li X; Zhang L; Xu Y; Wang M; Liang L; Jiao P; Li Y; He S; Du J; He L; Tang M; Sun M; Yang L; Di J; Zhu G; Li L; Liu D
Cancer Med; 2021 May; 10(10):3323-3331. PubMed ID: 33932095
[TBL] [Abstract][Full Text] [Related]
14. Multigene PCR using both cfDNA and cfRNA in the supernatant of pleural effusion achieves accurate and rapid detection of mutations and fusions of driver genes in patients with advanced NSCLC.
Chen X; Li K; Liu Z; Gai F; Zhu G; Lu S; Che N
Cancer Med; 2021 Apr; 10(7):2286-2292. PubMed ID: 33656807
[TBL] [Abstract][Full Text] [Related]
15. Molecular Profiling of Malignant Pleural Effusions with Next Generation Sequencing (NGS): Evidence that Supports Its Role in Cancer Management.
Grigoriadou GΙ; Esagian SM; Ryu HS; Nikas IP
J Pers Med; 2020 Nov; 10(4):. PubMed ID: 33139621
[TBL] [Abstract][Full Text] [Related]
16. Molecular Profiling for Supernatants and Matched Cell Pellets of Pleural Effusions in Non-Small-Cell Lung Cancer.
Xiang C; Huo M; Ma S; Guo L; Zhao R; Teng H; Zhang J; Han Y
J Mol Diagn; 2020 Apr; 22(4):513-522. PubMed ID: 32036088
[TBL] [Abstract][Full Text] [Related]
17. Malignant pleural effusion supernatant is an alternative liquid biopsy specimen for comprehensive mutational profiling.
Guo Z; Xie Z; Shi H; Du W; Peng L; Han W; Duan F; Zhang X; Chen M; Duan J; Lin J; Chen X; Lizaso AA; Han-Zhang H; He J; Yin W
Thorac Cancer; 2019 Apr; 10(4):823-831. PubMed ID: 30779318
[TBL] [Abstract][Full Text] [Related]
18. Distinct profile of cell-free DNA in malignant pleural effusion of non-small cell lung cancer and its impact on clinical genetic testing.
Yu Y; Qian J; Shen L; Ji W; Lu S
Int J Med Sci; 2021; 18(6):1510-1518. PubMed ID: 33628109
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
